McBride (MCB) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
8 Jul, 2026Executive summary
Achieved strong financial performance with sustained profit levels and a stronger business profile, supporting the reinstatement of annual dividends after five years.
Business transformation and operational improvements have doubled EBITDA returns from historic levels and normalized the balance sheet, with the transformation programme delivering positive results and £50m net benefits on track.
Maintained high service levels, improved sustainability metrics, and continued progress on strategic growth agenda.
Financial highlights
Group revenue for FY2025 was £926.5m, up 0.7% at constant currency, but down 1.9% on actual basis due to currency effects.
Adjusted operating profit held at £66.1m, similar to last year.
Adjusted EBITDA of £85.8m, margin steady at 9.3%.
Free cash flow reached £93.9m; net debt reduced to £105.2m, with net debt cover improved to 1.2x from 1.5x.
Dividend of 3.0p per share recommended for FY2025.
Outlook and guidance
Solid start to the new financial year with volumes in line with expectations and a robust pipeline of new business and product launches.
Continued focus on operational efficiency, transformation program, and cost control to support midterm ambition of 10% EBITDA.
Leadership exploring investment options to scale and create value for shareholders, supported by a strong financial position.
Latest events from McBride
- FY26 and FY27 adjusted EBITA guidance cut by 5–10% due to input cost pressures; Eurotab deal closing soon.MCB
Trading update12 Jun 2026 - Revenue and profitability rose, driven by private label growth and disciplined cost control.MCB
H1 202626 Feb 2026 - Profit growth, margin recovery, and lower net debt drive a confident outlook.MCB
H2 202420 Feb 2026 - Adjusted operating profit on track, with revenue and volume growth supporting future gains.MCB
Trading update20 Jan 2026 - Revenue up, net debt down, and contract manufacturing volumes surged 48.9%.MCB
H2 2025 TU16 Jul 2025 - Profit, cash flow, and private label growth enabled dividend plans amid ongoing transformation.MCB
H1 20256 Jun 2025